Essential thread by Melissa Barber at MSF if you want to understand how pharma IP is not only a pricing issue but absolute supply of essential medicines
Today, MSF is going public with something we've been fighting behind closed doors for months: Gilead will not sell us their new HIV drug, lenacapavir.
The sticking point isn't even price, they just refuse to sell.
Open letter linked + explainer 🧵1/
www.doctorswithoutborders.org/latest/gilea...